National Ask the Doctor About Lymphoma: Information for Relapsed/Refractory Patients – May 17, 2023

Ask The Doctor

This Ask the Doctor About Lymphoma will be a virtual program to deliver live patient education programming during the COVID-19 pandemic. This program will still provide access to local lymphoma experts, and you can tune in over the phone or online. Please continue to check this page for updates. As this program is not recorded or archived, we encourage you to tune in live.

VIRTUAL – Ask the Doctor About Lymphoma

DATE: Wednesday, May 17, 2023
TIME: 1:00 PM – 3:00 PM ET

VIRTUAL PROGRAM – This is a virtual Zoom event, accessible online and over the phone. Access instructions will be emailed after registration. If you are new to Zoom, learn more here: How-Do-I-Join-or-Test-My-Computer-Audio

Topic

This program is for lymphoma/CLL patients whose disease has returned or is no longer responding to treatment.

Program Overview

  • Lymphoma Overview
  • Who Might Experience Relapse?
  • Treatment Options Available to Relapsed/Refractory Patients
  • Questions to Ask Your Healthcare Team
  • Relapsed/Refractory Lymphoma and CLL Resources
  • Question and Answer Session

Featuring

Peter Martin, MD
Hematologist/Oncologist
Associate Professor of Medicine
Chief of the Lymphoma Program
Weill Cornell Medicine

Ways to Register

VIRTUAL PROGRAM – This is a virtual Zoom event, accessible online and over the phone. Access instructions will be emailed after registration. If you are new to Zoom, learn more here: How-Do-I-Join-or-Test-My-Computer-Audio

Call: 800-500-9976
Email: mspellman@lymphoma.org

This program is for patients and survivors, caregivers and program supporters. If you are a pharmaceutical industry professional that is interested in attending but your company is not listed as a sponsor, please email vgonzalez@lymphoma.org to learn more about sponsorship.

Disclaimer: The Lymphoma Research Foundation (LRF) is a national nonprofit organization based in the United States with educational programs and resources are intended for a US-based audience. These program and resources address available lymphoma treatments in the United States. and information on drug approvals by the US Food and Drug Administration.

For individuals outside of the US, LRF recommends the Lymphoma Coalition at www.lymphomacoalition.org. The Lymphoma Coalition is a global network of worldwide nonprofit/NGO lymphoma patient organizations with information appropriate for non US-based audiences.

Program Supporters

This program is supported through unrestricted educational grants from: